Watnick Suzanne, Kirwin Paul, Mahnensmith Rex, Concato John
Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.
Am J Kidney Dis. 2003 Jan;41(1):105-10. doi: 10.1053/ajkd.2003.50029.
Depression is common in patients with end-stage renal disease (ESRD) and is associated with increased mortality, but little is known about depression in patients just after they start dialysis therapy. We sought to assess the prevalence of depressive symptoms in patients with ESRD starting dialysis therapy, identify patient characteristics associated with depression, and determine whether patients with serious depressive symptoms were receiving treatment.
We implemented a multicenter prospective cohort study at 14 dialysis centers in Connecticut. Patients with ESRD who were 18 years and older were interviewed within 10 days of initiating dialysis therapy between November 2000 and July 2001. The Beck Depression Inventory (BDI) was used to assess depressive symptoms. Chi-square tests were used to evaluate associations between several patient characteristics and depression, and multivariable logistic regression models were used to determine odds ratios (ORs) for depression, with adjustment for baseline variables.
Among 123 patients, 44% (54 of 123 patients) had scores above the validated cutoff value in the BDI for depression. In logistic regression analysis, depression was statistically significantly associated with Caucasian race (OR, 3.4; P = 0.02), lower self-rated quality of life (OR, 2.2; P = 0.003), and no previous acquaintances on dialysis therapy (OR, 10.2; P = 0.03). Only 16% (9 of 54 patients) of depressed patients were being treated at enrollment; 13% (5 of 38 patients) of those with mild symptoms and 25% (4 of 16 patients) with more severe symptoms were being treated.
Our results show that depressive symptoms are very common at the start of dialysis therapy, and specific characteristics are associated with a greater burden of depressive symptoms. Despite a high prevalence, treatment rates are low, even among patients with moderate to severe symptoms of depression.
抑郁症在终末期肾病(ESRD)患者中很常见,且与死亡率增加相关,但对于刚开始接受透析治疗的患者的抑郁症情况知之甚少。我们试图评估开始透析治疗的ESRD患者中抑郁症状的患病率,确定与抑郁症相关的患者特征,并确定有严重抑郁症状的患者是否正在接受治疗。
我们在康涅狄格州的14个透析中心开展了一项多中心前瞻性队列研究。2000年11月至2001年7月期间,对18岁及以上的ESRD患者在开始透析治疗的10天内进行了访谈。使用贝克抑郁量表(BDI)评估抑郁症状。采用卡方检验评估几种患者特征与抑郁症之间的关联,并使用多变量逻辑回归模型确定抑郁症的比值比(OR),同时对基线变量进行调整。
在123例患者中,44%(123例患者中的54例)的BDI抑郁评分高于验证后的临界值。在逻辑回归分析中,抑郁症与白人种族(OR,3.4;P = 0.02)、自评生活质量较低(OR,2.2;P = 0.003)以及透析治疗前没有熟人(OR,10.2;P = 0.03)在统计学上显著相关。入组时,只有16%(54例患者中的9例)的抑郁症患者正在接受治疗;症状较轻的患者中有13%(38例患者中的5例)正在接受治疗,症状较严重的患者中有25%(16例患者中的4例)正在接受治疗。
我们的结果表明,抑郁症状在透析治疗开始时非常常见,特定特征与更严重的抑郁症状负担相关。尽管患病率很高,但治疗率很低,即使在有中度至重度抑郁症状的患者中也是如此。